Relationship between cardiovascular dysfunction and hyperglycemia in streptozotocin-induced diabetes in rats

Streptozotocin (STZ)-induced diabetes in rats is characterized by cardiovascular dysfunction beginning 5 days after STZ injection, which may reflect functional or structural autonomic nervous system damage. We investigated cardiovascular and autonomic function, in rats weighing 166 ± 4 g, 5-7, 14, 30, 45, and 90 days after STZ injection (N = 24, 33, 27, 14, and 13, respectively). Arterial pressure (AP), mean AP (MAP) variability (standard deviation of the mean of MAP, SDMMAP), heart rate (HR), HR variability (standard deviation of the normal pulse intervals, SDNN), and root mean square of successive difference of pulse intervals (RMSSD) were measured. STZ induced increased glycemia in diabetic rats vs control rats. Diabetes reduced resting HR from 363 ± 12 to 332 ± 5 bpm (P < 0.05) 5 to 7 days after STZ and reduced MAP from 121 ± 2 to 104 ± 5 mmHg (P = 0.007) 14 days after STZ. HR and MAP variability were lower in diabetic vs control rats 30-45 days after STZ injection (RMSSD decreased from 5.6 ± 0.9 to 3.4 ± 0.4 ms, P = 0.04 and SDMMAP from 6.6 ± 0.6 to 4.2 ± 0.6 mmHg, P = 0.005). Glycemia was negatively correlated with resting AP and HR (r = -0.41 and -0.40, P < 0.001) and with SDNN and SDMMAP indices (r = -0.34 and -0.49, P < 0.01). Even though STZ-diabetic rats presented bradycardia and hypotension early in the course of diabetes, their autonomic function was reduced only 30-45 days after STZ injection and these changes were negatively correlated with plasma glucose, suggesting a metabolic origin.

Saved in:
Bibliographic Details
Main Authors: Schaan,B.D., Dall'Ago,P., Maeda,C.Y., Ferlin,E., Fernandes,T.G., Schmid,H., Irigoyen,M.C.
Format: Digital revista
Language:English
Published: Associação Brasileira de Divulgação Científica 2004
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2004001200016
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0100-879X2004001200016
record_format ojs
spelling oai:scielo:S0100-879X20040012000162004-11-17Relationship between cardiovascular dysfunction and hyperglycemia in streptozotocin-induced diabetes in ratsSchaan,B.D.Dall'Ago,P.Maeda,C.Y.Ferlin,E.Fernandes,T.G.Schmid,H.Irigoyen,M.C. Diabetes Streptozotocin Heart rate variability Rats Autonomic nervous system Arterial pressure variability Streptozotocin (STZ)-induced diabetes in rats is characterized by cardiovascular dysfunction beginning 5 days after STZ injection, which may reflect functional or structural autonomic nervous system damage. We investigated cardiovascular and autonomic function, in rats weighing 166 ± 4 g, 5-7, 14, 30, 45, and 90 days after STZ injection (N = 24, 33, 27, 14, and 13, respectively). Arterial pressure (AP), mean AP (MAP) variability (standard deviation of the mean of MAP, SDMMAP), heart rate (HR), HR variability (standard deviation of the normal pulse intervals, SDNN), and root mean square of successive difference of pulse intervals (RMSSD) were measured. STZ induced increased glycemia in diabetic rats vs control rats. Diabetes reduced resting HR from 363 ± 12 to 332 ± 5 bpm (P < 0.05) 5 to 7 days after STZ and reduced MAP from 121 ± 2 to 104 ± 5 mmHg (P = 0.007) 14 days after STZ. HR and MAP variability were lower in diabetic vs control rats 30-45 days after STZ injection (RMSSD decreased from 5.6 ± 0.9 to 3.4 ± 0.4 ms, P = 0.04 and SDMMAP from 6.6 ± 0.6 to 4.2 ± 0.6 mmHg, P = 0.005). Glycemia was negatively correlated with resting AP and HR (r = -0.41 and -0.40, P < 0.001) and with SDNN and SDMMAP indices (r = -0.34 and -0.49, P < 0.01). Even though STZ-diabetic rats presented bradycardia and hypotension early in the course of diabetes, their autonomic function was reduced only 30-45 days after STZ injection and these changes were negatively correlated with plasma glucose, suggesting a metabolic origin.info:eu-repo/semantics/openAccessAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research v.37 n.12 20042004-12-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2004001200016en10.1590/S0100-879X2004001200016
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Schaan,B.D.
Dall'Ago,P.
Maeda,C.Y.
Ferlin,E.
Fernandes,T.G.
Schmid,H.
Irigoyen,M.C.
spellingShingle Schaan,B.D.
Dall'Ago,P.
Maeda,C.Y.
Ferlin,E.
Fernandes,T.G.
Schmid,H.
Irigoyen,M.C.
Relationship between cardiovascular dysfunction and hyperglycemia in streptozotocin-induced diabetes in rats
author_facet Schaan,B.D.
Dall'Ago,P.
Maeda,C.Y.
Ferlin,E.
Fernandes,T.G.
Schmid,H.
Irigoyen,M.C.
author_sort Schaan,B.D.
title Relationship between cardiovascular dysfunction and hyperglycemia in streptozotocin-induced diabetes in rats
title_short Relationship between cardiovascular dysfunction and hyperglycemia in streptozotocin-induced diabetes in rats
title_full Relationship between cardiovascular dysfunction and hyperglycemia in streptozotocin-induced diabetes in rats
title_fullStr Relationship between cardiovascular dysfunction and hyperglycemia in streptozotocin-induced diabetes in rats
title_full_unstemmed Relationship between cardiovascular dysfunction and hyperglycemia in streptozotocin-induced diabetes in rats
title_sort relationship between cardiovascular dysfunction and hyperglycemia in streptozotocin-induced diabetes in rats
description Streptozotocin (STZ)-induced diabetes in rats is characterized by cardiovascular dysfunction beginning 5 days after STZ injection, which may reflect functional or structural autonomic nervous system damage. We investigated cardiovascular and autonomic function, in rats weighing 166 ± 4 g, 5-7, 14, 30, 45, and 90 days after STZ injection (N = 24, 33, 27, 14, and 13, respectively). Arterial pressure (AP), mean AP (MAP) variability (standard deviation of the mean of MAP, SDMMAP), heart rate (HR), HR variability (standard deviation of the normal pulse intervals, SDNN), and root mean square of successive difference of pulse intervals (RMSSD) were measured. STZ induced increased glycemia in diabetic rats vs control rats. Diabetes reduced resting HR from 363 ± 12 to 332 ± 5 bpm (P < 0.05) 5 to 7 days after STZ and reduced MAP from 121 ± 2 to 104 ± 5 mmHg (P = 0.007) 14 days after STZ. HR and MAP variability were lower in diabetic vs control rats 30-45 days after STZ injection (RMSSD decreased from 5.6 ± 0.9 to 3.4 ± 0.4 ms, P = 0.04 and SDMMAP from 6.6 ± 0.6 to 4.2 ± 0.6 mmHg, P = 0.005). Glycemia was negatively correlated with resting AP and HR (r = -0.41 and -0.40, P < 0.001) and with SDNN and SDMMAP indices (r = -0.34 and -0.49, P < 0.01). Even though STZ-diabetic rats presented bradycardia and hypotension early in the course of diabetes, their autonomic function was reduced only 30-45 days after STZ injection and these changes were negatively correlated with plasma glucose, suggesting a metabolic origin.
publisher Associação Brasileira de Divulgação Científica
publishDate 2004
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2004001200016
work_keys_str_mv AT schaanbd relationshipbetweencardiovasculardysfunctionandhyperglycemiainstreptozotocininduceddiabetesinrats
AT dallagop relationshipbetweencardiovasculardysfunctionandhyperglycemiainstreptozotocininduceddiabetesinrats
AT maedacy relationshipbetweencardiovasculardysfunctionandhyperglycemiainstreptozotocininduceddiabetesinrats
AT ferline relationshipbetweencardiovasculardysfunctionandhyperglycemiainstreptozotocininduceddiabetesinrats
AT fernandestg relationshipbetweencardiovasculardysfunctionandhyperglycemiainstreptozotocininduceddiabetesinrats
AT schmidh relationshipbetweencardiovasculardysfunctionandhyperglycemiainstreptozotocininduceddiabetesinrats
AT irigoyenmc relationshipbetweencardiovasculardysfunctionandhyperglycemiainstreptozotocininduceddiabetesinrats
_version_ 1756391100169322496